carvedilol has been researched along with Amyloid Neuropathy Type 1 in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carvedilol is a β-antagonist with strong anti-oxidant effect in lipids, proteins and superoxide production protecting biological membranes from oxidative stress." | 1.36 | Carvedilol treatment reduces transthyretin deposition in a familial amyloidotic polyneuropathy mouse model. ( Batista, AR; Macedo, B; Magalhães, J; Saraiva, MJ, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Macedo, B | 1 |
| Magalhães, J | 1 |
| Batista, AR | 1 |
| Saraiva, MJ | 1 |
1 other study available for carvedilol and Amyloid Neuropathy Type 1
| Article | Year |
|---|---|
Carvedilol treatment reduces transthyretin deposition in a familial amyloidotic polyneuropathy mouse model.
Topics: Adrenergic beta-Antagonists; Amyloid Neuropathies, Familial; Animals; Antioxidants; Apoptosis; Carba | 2010 |